The histologic response to induction therapy is usually a binary function. In the current study, the authors explored methods of refining the histologic response classification to improve prediction of prognosis for patients with esophageal adenocarcinoma. They identified 3 unique groups: major response in the primary tumor with ypN0; either major response with ypN+ or minor response with ypN0; minor response and ypN+. The 5-yr survivals were 64%, 42%, and 18%, respectively.
You are here:
Prognostic Classification of Histopathologic Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma
Submitted by: Mark Ferguson
Source: Annals of Surgery
Keywords:
Author(s): Hölscher, Arnulf H.; Drebber, Uta; Schmidt, Henner; Bollschweiler, Efriede
